Russell Frank Company’s Medifast MED Stock Holding History

Russell Frank Company’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.1M	Buy	36,600 +19,900	+119%	+$582K	﹤0.01%	2129
2015 Q4	$510K	Buy	+16,700	New	+$497K	﹤0.01%	2483
2015 Q3	–	Sell	-32,984	Closed	-$1.07M	–	3029
2015 Q2	$1.07M	Sell	32,984 -43,003	-57%	-$1.36M	﹤0.01%	2278
2015 Q1	$2.28M	Buy	75,987 +2,600	+4%	+$82.5K	﹤0.01%	1698
2014 Q4	$2.46M	Sell	73,387 -49,457	-40%	-$1.54M	﹤0.01%	1661
2014 Q3	$4.03M	Sell	122,844 -50,427	-29%	-$1.55M	0.01%	1416
2014 Q2	$4.97M	Buy	173,271 +39,131	+29%	+$1.22M	0.01%	1320
2014 Q1	$3.9M	Hold	134,140	–	–	0.01%	1417
2013 Q4	$3.49M	Sell	134,140 -34,333	-20%	-$880K	0.01%	1426
2013 Q3	$4.53M	Buy	168,473 +26,612	+19%	+$712K	0.01%	1387
2013 Q2	$3.65M	Buy	+141,861	New	+$3.73M	0.01%	1430

Other funds holding MED

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Russell Frank Company's MED Position: Q1 2016 in Review

Russell Frank Company increased its Medifast (MED) stake by 119% in Q1 2016, buying an estimated $582K and bringing the position to 36,600 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

Russell Frank Company first reported a position in MED in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.97M in Q2 2014. 133 funds tracked by Wall St. Rank hold MED as of Q1 2016.

Russell Frank Company held 36,600 shares of Medifast worth $1.1M as of Q1 2016.
Russell Frank Company bought 19,900 Medifast shares in Q1 2016, an estimated $582K.
Medifast made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2129 holding.
Russell Frank Company first reported a position in Medifast in Q2 2013 and has held it in 11 quarters since.
Russell Frank Company's Medifast position peaked at $4.97M in Q2 2014.
133 funds tracked by Wall St. Rank held Medifast as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.